Anti-inflammatory Uzbekistan Licorice Root Extract for Joint and Skin Formulations

2025-11-16 12:01

Anti-inflammatory Uzbekistan Licorice Root Extract for Joint and Skin FormulationsIncorporate Blue Eyes Biotech's anti-inflammatory Uzbekistan Licorice Root Extract into joint and skincare products, with 96% purity and proven reduction in inflammation markers.

anti-inflammatory licorice extract, Uzbekistan licorice root, joint health, skincare ingredients, natural anti-inflammatories, Blue Eyes Biotech

#AntiInflammatory #JointHealth #SkincareIngredients #NaturalRemedies #BlueEyesBiotech



Chronic inflammation drives conditions from arthritis to dermatitis, yet many natural anti-inflammatories fail to deliver consistent results

due to poor bioavailability. Blue Eyes Biotech CO., Ltd. tackles this with our Uzbekistan Licorice Root Extract, engineered for superior

anti-inflammatory action. Sourced from Uzbekistan’s pristine ecosystems, this licorice root extract features a 96% purity rate, with enhanced

absorption through nano-emulsification technology.


The complexity of isolating licochalcone A and glabridin—key anti-inflammatory compounds—poses a significant technical hurdle.

Our enzymatic extraction method maximizes their concentration, ensuring our Uzbekistan Licorice Root Extract reduces COX-2 enzyme

activity by up to 60% in vitro. For buyers in the cosmetic and pharmaceutical industries, this translates to potent ingredients for topica

l creams, capsules, and injectables. Clinical data shows a 50% improvement in skin hydration and joint mobility within weeks.


Procurement should focus on suppliers who validate claims with robust science. Blue Eyes Biotech’s Uzbekistan Licorice Root Extract is

supported by animal and human studies, available for review. It’s an ideal choice for brands aiming to combine nature and innovation.

Don’t let inflammation limit your products—inquire at [email protected] or www.blueeyes-bio.com to access samples and technical

support.


Name:
Message:
Verification code:
Submit
Comment